Olympic Therapeutics was formed by specialists to develop a new class of Antifungal Medications for the treatment of resistant Fungal Infections.
Over 300 Mln. peoples worldwide infected.
25 Mln. are at high risk of dying or decline.
develops a new class of Antifungal Medications
Initial License Offering
Globally, over 300 million people are afflicted with a serious fungal infection and 25 milllion are at high risk of dying or losing their sight.
For years, we have been researching the treatment of complicated fungal diseases and have successfully started to develop appropriate drugs.
In order to bring our previous research results and the associated drugs to market, Olympic Therapeutics AG was founded by researchers and scientists.
Olympic Therapeutics AG Team
Hans Werner Balz is MBA and has many years in experience in the pharma business as certified clinical consultant and as Director of a global acting pharma company.
Chief Scientific Director(CSD, USA Division)Read More
Chief Scientific Director(CSD, USA Division)
Dr Honour is a PhD and responsible for Research and Product Development. He has decades of experience in the industry at senior executive levels and various board of director positions. He is known world wide for his expertise in bacteriophages and infectious diseases.
Chief Product Development and Business Director(CPDBD, USA Division)Read More
Chief Product Development and Business Director(CPDBD, USA Division)
Dr Wheeler is an MD, MBA, and has decades of global experience in the development of successful biopharmaceuticals. In addition, he has held significant senior level executive positions in the industry. He currently serves on the Board of Directors of three companies.
President of the Supervisory BoardRead More
President of the Supervisory Board
Mr. Heinzelmann has long year is a trained banker and has many years of experience as CFO of a bank and is CEO of a exchange listed finance company. Mr. Heinzelmann is also in the supervisory board of a German software company.
Member of Supervisory BoardRead More
Member of Supervisory Board
Mr. Colshorn has a diploma from the University of Stuttgart and many years of experience as a supervisory board member and director of various companies.
More information about Olympic Therapeutics AG